Related Experiment Videos
Bone resorption inhibitors from hop extract
1Pharma Research and Development Division, Hoechst Japan Limited, Saitama, Japan.
Bioscience, Biotechnology, and Biochemistry
|January 1, 1997
Summary
Hop extract contains xanthohumol and humulone, which inhibit bone resorption. Humulone demonstrated exceptionally potent activity, with a 50% inhibition concentration of 5.9 x 10(-9)M.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Bone Biology
Background:
- Bone resorption is a critical process in skeletal remodeling and disease.
- Identifying natural compounds that modulate bone resorption is of therapeutic interest.
Purpose of the Study:
- To identify active components from hop extract that inhibit bone resorption.
- To characterize the inhibitory potential of isolated compounds.
Main Methods:
- Screening of hop extract using the pit formation assay.
- Isolation and identification of active compounds.
- Determination of inhibitory concentration (IC50) values.
Main Results:
- Xanthohumol and humulone were identified as active components from hop extract.
- Humulone exhibited potent inhibition of bone resorption.
- The IC50 value for humulone was determined to be 5.9 x 10(-9)M.
Conclusions:
- Hop extract contains compounds with anti-resorptive properties.
- Humulone is a highly effective inhibitor of bone resorption.
- These findings suggest potential therapeutic applications for humulone in bone-related disorders.